India’s Ranbaxy Lab says gets FDA approval for pain relief drugs
MUMBAI, Aug. 20, 2007 (Thomson Financial delivered by Newstex) — Indian pharma company Ranbaxy Laboratories Ltd said it secured Food and Drug Administration approval to manufacture and sell pain relief drugs Hydrocodone Bitartrate and Acetaminophen tablets US Pharmacopeia (NASDAQ:PCOP) in the US.
Jim Meehan, vice president of sales and marketing, Ranbaxy Pharmaceuticals Inc said the new drugs — to be launched in November — will further expand the company’s portfolio.
Internet Pharmacy - Buy Pharmacy at reasanoble prices.Internet Pharmacy provides confortable and easy way to order pharmacy via internet.
Annual sales for Hydrocodone Bitartrate and Acetaminophen tablets in 2006 was 390.6 mln usd, Ranbaxy said in a statement to the Bombay (OTCBB:BBAO) Stock Exchange.
Copyright AFX News Limited 2007. All rights reserved.
The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News.